Bank of New York Mellon
CDLX icon

Bank of New York Mellon’s Cardlytics CDLX Stock Holding History

Bank of New York Mellon’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,061
Closed -$183K – 4159
2025
Q1 		$183K Buy
10,061
+167
+2% +$4.77K ﹤0.01% 3909
2024
Q4 		$367K Sell
9,894
-468
-5% -$17.9K ﹤0.01% 3678
2024
Q3 		$332K Sell
10,362
-3,230
-24% -$179K ﹤0.01% 3713
2024
Q2 		$1.12M Buy
13,592
+1,817
+15% +$196K ﹤0.01% 3131
2024
Q1 		$1.71M Sell
11,775
-1,276
-10% -$108K ﹤0.01% 2851
2023
Q4 		$1.2M Buy
13,051
+738
+6% +$75K ﹤0.01% 3095
2023
Q3 		$2.03M Sell
12,313
-67
-0.5% -$8.71K ﹤0.01% 2800
2023
Q2 		$782K Buy
12,380
+1,314
+12% +$79.6K ﹤0.01% 3347
2023
Q1 		$376K Sell
11,066
-652
-6% -$34.1K ﹤0.01% 3644
2022
Q4 		$677K Sell
11,718
-33,335
-74% -$2.06M ﹤0.01% 3391
2022
Q3 		$4.24M Buy
45,053
+170
+0.4% +$24.2K ﹤0.01% 2374
2022
Q2 		$10M Sell
44,883
-17,080
-28% -$5.72M ﹤0.01% 1935
2022
Q1 		$34.1M Sell
61,963
-4,725
-7% -$2.86M 0.01% 1351
2021
Q4 		$44.1M Sell
66,688
-3,068
-4% -$2.35M 0.01% 1249
2021
Q3 		$58.6M Buy
69,756
+38,497
+123% +$39.1M 0.01% 1030
2021
Q2 		$39.7M Sell
31,259
-157
-0.5% -$177K 0.01% 1311
2021
Q1 		$34.5M Sell
31,416
-6,196
-16% -$8.18M 0.01% 1366
2020
Q4 		$53.7M Sell
37,612
-14,263
-27% -$15.2M 0.01% 1011
2020
Q3 		$36.6M Buy
51,875
+3,863
+8% +$2.81M 0.01% 1095
2020
Q2 		$33.6M Buy
48,012
+1,312
+3% +$758K 0.01% 1123
2020
Q1 		$16.3M Buy
46,700
+2,675
+6% +$1.89M 0.01% 1418
2019
Q4 		$27.7M Buy
44,025
+34,266
+351% +$16.8M 0.01% 1379
2019
Q3 		$3.27M Buy
9,759
+4,206
+76% +$1.35M ﹤0.01% 2488
2019
Q2 		$1.44M Buy
5,553
+3,535
+175% +$708K ﹤0.01% 2994
2019
Q1 		$334K Buy
2,018
+84
+4% +$13.7K ﹤0.01% 3711
2018
Q4 		$209K Buy
1,934
+31
+2% +$5.23K ﹤0.01% 3840
2018
Q3 		$477K Buy
1,903
+348
+22% +$74.9K ﹤0.01% 3671
2018
Q2 		$338K Buy
1,555
+384
+33% +$71.1K ﹤0.01% 3794
2018
Q1 		$171K Buy
+1,171
New +$198K ﹤0.01% 3961

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $126M AUM 53.89% 1-Year Est. Return

Bank of New York Mellon's CDLX Position: Q2 2025 in Review

Bank of New York Mellon sold out of Cardlytics (CDLX) in Q2 2025, closing a stake of 10,061 shares — an estimated $183K sold.

Bank of New York Mellon first reported a position in CDLX in Q1 2018 and held it in 29 quarters. The position peaked at $58.6M in Q3 2021. 89 funds tracked by Wall St. Rank hold CDLX as of Q2 2025.

  • Bank of New York Mellon reported no remaining Cardlytics position as of Q2 2025 after selling out during the quarter.
  • Bank of New York Mellon sold 10,061 Cardlytics shares in Q2 2025, an estimated $183K.
  • Bank of New York Mellon first reported a position in Cardlytics in Q1 2018 and held it in 29 quarters.
  • Bank of New York Mellon's Cardlytics position peaked at $58.6M in Q3 2021.
  • 89 funds tracked by Wall St. Rank held Cardlytics as of Q2 2025.

Based on Bank of New York Mellon's 13F filing for Q2 2025, filed 5 Aug 2025.